Because ALS/PDC is associated with tau pathology in the absence of amyloid plaques, the expectation was that ALS/PDC patients would not show the Alzheimer's disease (AD) profile of decreased Aβ42 but might show increased t-tau and/or p-tau in the CSF. Here, MAPT is linked to Alzheimer disease.